Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cytochrome c oxidase subunit 6C pseudogene 8 (COX6CP8) is a pseudogene related to cytochrome c oxidase subunit 6C (COX6C), a structural component of complex IV in the mitochondrial electron transport chain[1][3][5]. As a pseudogene, COX6CP8 does not encode a functional protein and is generally considered biologically inactive, except in rare instances where pseudogenes may transcribe RNA with regulatory functions[4][6]. There is no evidence that COX6CP8 protein is expressed, nor does it contribute directly to mitochondrial electron transport or other cellular pathways. Pseudogenes like COX6CP8 are not recognized as drug targets, have no disease roles, no known interacting drugs, and no associated biomarkers or safety concerns. In summary, COX6CP8 is not a canonical therapeutic target but an inactive genetic element[1][3][5][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytochrome c oxidase subunit 6C pseudogene 8 (COX6CP8).